Alphamab Oncology has announced the grant of award shares under its Restricted Share Award Scheme, as disclosed in a recent filing with The Stock Exchange of Hong Kong Limited. The company aims to recognize and reward the contributions of its Award Directors, providing them with shares as part of their compensation. The shares granted to the Award Directors do not have specific performance targets, aligning with the company's remuneration policy. This initiative is part of the company's efforts to closely align the interests of its shareholders, the company, and its directors. The announcement, made by Chairman Dr. Xu Ting, highlights the company's focus on its continual operation and long-term growth.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。